Incretin responses are the body’s natural hormonal amplification of insulin release after eating, triggered by GLP-1 and GIP. This mechanism regulates post-meal blood sugar, slows digestion, and curbs appetite. Clinically, it’s harnessed in diabetes and obesity treatments, benefiting patients with type 2 diabetes, metabolic syndrome, or weight management needs.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends